Development of in situ-gelling and mucoadhesive liquid suppository of ondansetron

International Journal of ChemTech Research

Volumn 1, Issue 4, 2009, Pages 953-961

  Jadhav, U G ^a   Dias, R J ^a   Mali, K K ^a   Havaldar, V D ^a  

^a Behind Spicer India Ltd   (India)

Author keywords

Gelation temperature; Liquid suppository; Mucoadhesive polymer; Ondansetron; Poloxamer; Polyethylene glycol; Thermally gelling

Indexed keywords

ALGINIC ACID; MACROGOL; METHYLCELLULOSE; ONDANSETRON; POLOXAMER; POVIDONE;

ARTICLE; DRUG RELEASE; GELATION; MUCOADHESION; SUPPOSITORY; VISCOSITY;

EID: 77953412369     PISSN: None     EISSN: 09744290     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Zempsky W.T., Cote C.J., Berlin C.M. Alternative routes of drug administration-advantages and disadvantages (Subject Review), Pediatrics, 1997, 100(1),143-152.
2. nd ed. New York: Marcel Dekker, 2002,932-944.
3. Huang C.H., Tokumura T., Machida Y. et al. Formulation of double-layered suppository for prolonged stay in lower rectum. Yakuzaigaku, 1987, 47,42-48.
4. Choi H.G., Jung J.H., Ryu J.M., et al. Development of in situ-gelling and mucoadhesive acetaminophen liquid suppository. Int J Pharm. 1998, 165,33-44.
5. Freitas M.N., Farah M., Bretas E.S. et al. Rheological characterization of poloxamer 407 nimesulide gels, Journal of basic and applied pharmaceutical science, 2006, 27(1),113-118.
6. Dumortier G., Grosslord J.L., Agnely F., et al. A review of poloxamer 407 pharmaceutical and pharmacological characteristics, Pharm Res, 2006, 23,2709-2727.
7. Legha S.S., Hodges C., Ring S. Efficacy of ondansetron against nausea vomiting caused by dacarbazine-containing chemotherapy, Cancer, 1992, 70(7),2018-2020.
8. Fumoleau P., Giovannini M., Rolland F., et al. Ondansetron suppository: an effective treatment for the prevention of emetic disorders induced by cisplatin-based chemotherapy, Oral Oncology, 1997, 33(5),354-358.
9. Schmolka I.R. Artificial Skin I: Preparation and properties of Pluronic-127 gels for treatment of burns, J Biomed Mater Res, 1972, 6,571-582.
10. Ryu J.M., Chung S.J., Lee M.H., et al. Increased bioavailability of propranolol in rats by retaining thermally gelling liquid suppositories in the rectum, J Control Rel, 1999, 59,163-172.
11. Fawaz F., Koffi A., Guyot M. et al., Comparative in vitro-in vivo study of two quinine rectal gel formulations, Int J Pharm, 2004, 280,151-162.
12. Abd ElHady S.S., Mortada N.D., Gehanne A.S., et al. Development of in situ gelling and mucoadhesive mebeverine hydrochloride solution for rectal administration, SPJ, 2003, 11,159-171.
13. Park J.Y., Yong S.C., Kim M.H., et al. Effect of sodium chloride on the release, absorption and safety of diclofenac sodium delivered by poloxamer gel. Int J Pharm, 2003, 263,105-111.
14. Kamel E.A., Khatib E.M., Thermally reversible in situ gelling carbamazepine liquid suppository, Drug Deliv, 2006, 13,143-148.
15. Gilbert J.C., Richardson J.L., Martyn C.D., et al. The effect of solutes and polymers on the gelation properties of Pluronic-F127 solutions for controlled drug delivery, J Control Release, 1987, 5,113-118.
16. Pisal S., Shelke V., Mahadik K., et al. Effect of organogel components on in vitro nasal delivery of propranolol hydrochloride, AAPS Pharm Sci Tech, 2004, 5,1-9.
17. Choi HG, Lee MK, Kim HM., et al. Effect of additives on the physicochemical properties of liquid suppository bases, Int J Pharm, 1999, 99,13-19.